Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

LXRX Lexicon Pharmaceuticals Inc

0,7035

-0,0099 (-1,39%)

Zuletzt aktualisiert: 16:22:37

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Lexicon Pharmaceuticals Charts.

Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Lexicon Pharmaceuticals Charts.

News Lexicon Pharmaceuticals Inc

Form 8-K - Current report
Dienstag 7 Januar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 2 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Donnerstag 2 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 2 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Lexicon Appoints Scott Coiante as Chief Financial Officer
Donnerstag 2 Januar 2025 (2 Wochen vor) • GlobeNewswire Inc.

Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (sotagliflozin)
Freitag 20 Dezember 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dienstag 10 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 2 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Lexicon Announces Completion of Enrollment in Phase 2B PROGRESS Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)
Dienstag 26 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Lexicon Pharmaceuticals to Participate in December Investor Conferences
Montag 25 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA
Freitag 22 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 20 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Lexicon Pharmaceuticals Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen